HIV Treatment-As-Prevention Research: Authors’ Reply

article has not abstract

Vyšlo v časopise: HIV Treatment-As-Prevention Research: Authors’ Reply. PLoS Med 12(3): e32767. doi:10.1371/journal.pmed.1001799
Kategorie: Formal Comment
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001799

Souhrn

article has not abstract

Zdroje

1. Hayes R, Fidler S, Cori A, Fraser C, Floyd S, et al. (2015) HIV treatment-as-prevention research: taking the right road at the crossroads. PLoS Med 12(3): e1001800. doi: 10.1371/journal.pmed.1001800

2. Bärnighausen T, Eyal N, Wikler D (2014) HIV treatment-as-prevention research at a crossroads. PLoS Med 11: e1001654. doi: 10.1371/journal.pmed.1001654 24892694

3. The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (2012) HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making. PLoS Med 9 e1001259. doi: 10.1371/journal.pmed.1001259 22802739

4. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48–57. doi: 10.1016/S0140-6736(08)61697-9 19038438

5. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, et al. (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 9: e1001245. doi: 10.1371/journal.pmed.1001245 22802730

6. Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ (2013) Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J Acquir Immune Defic Syndr 63 Suppl 2: S221–227. doi: 10.1097/QAI.0b013e318299c3f4 23764639

7. Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN (2011) Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 8: 62–72. doi: 10.1007/s11904-010-0063-3 20941553

8. Merson M, Padian N, Coates TJ, Gupta GR, Bertozzi SM, et al. (2008) Combination HIV prevention. Lancet 372: 1805–1806. doi: 10.1016/S0140-6736(08)61752-3 19027478

9. Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, et al. (2014) HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment—a study protocol for a cluster randomised trial. Trials 15: 57. doi: 10.1186/1745-6215-15-57 24524229

10. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents (2013) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

11. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 308: 387–402. doi: 10.1001/jama.2012.7961 22820792

12. WHO (2014) Systematic reviews to support the antiretroviral therapy (ART) consolidated guidelines Geneva: WHO.

13. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643–656. 17321310

14. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666. 17321311

15. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2: e298. 16231970